Prevail Therapeutics
Biotechnology Research • 
Manhattan, New York, United States • 21-50 Employees
Company overview
| Headquarters | 430 E 29th St, New York, 10016, US |
| Phone number | +19173369310 |
| Website | |
| SIC | 873 |
| Keywords | Biotechnology, Gene Therapy, CMC, Regulatory, Pharmaceuticals, Discovery, Clinical, Neurodegenerative Diseases, Drug Development, Parkinson'S Disease |
| Founded | 2017 |
| Employees | 21-50 |
| Socials |
Key Contacts at Prevail Therapeutics
Vivek Trivedi
Executive Medical Director
Yael Beckerman
Associate Director, Clinical Operations
Paul Tamburri
Director Clinical Development
Shital Kakkar
Senior Director, Quality Assurance
Ming Yang
Director
Lynne Verselis
Director, Clinical Development
Michelle Faver
Associate Director Clinical Operations
Jingmin Zhou
Director
Prevail Therapeutics Email Formats
Prevail Therapeutics uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@prevailtherapeutics.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@prevailtherapeutics.com | 100% |
About Prevail Therapeutics
At Prevail Therapeutics, we are developing novel gene therapies that target the root genetic causes of Parkinson’s disease and other neurodegenerative disorders. Our mission is to translate recent advances in human genetics and gene therapy technology into medicines that slow or stop the neurodegenerative process. Our programs utilize a precision medicine approach targeting patient populations with urgent unmet needs, where there are currently no available therapies that modify the progressive course of their disorders. Prevail was formed in 2017 and we are building a team of dedicated, creative and talented individuals who share our passion for serving patients with neurodegenerative diseases. We pride ourselves on following great science, and we value collaboration, integrity and agility. We are based in the Alexandria Center for Life Science in New York City. Prevail Therapeutics was acquired by Eli Lilly and Company in January of 2021, and is now a wholly owned subsidiary of Eli Lilly. For information please visit the www.lilly.com website.
Prevail Therapeutics revenue & valuation
| Annual revenue | $74,300,000 |
| Revenue per employee | $3,231,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $237,800,000 |
| Total funding | $50,000,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Prevail Therapeutics has 8 employees across 3 departments.
Departments
Number of employees
Prevail Therapeutics Tech Stack
Discover the technologies and tools that power Prevail Therapeutics's digital infrastructure, from frameworks to analytics platforms.
CDN
JavaScript libraries
Font scripts
Web servers
Miscellaneous
Programming languages
Miscellaneous
Font scripts
Blogs
JavaScript libraries
CDN
Databases
Ireland
Netherlands
Portugal
Czechia
Canada
Frequently asked questions
4.8
40,000 users
